|
2014, Volume 60, Issue 3 |
| REVIEWS |
| 281-294 |
Trifonova O.P., Lokhov P.G., Archakov A.I.
Metabolic profiling of human blood
|
   |
| MISCELLANEOUS |
| 295-307 |
Vavilova T.P., Ostrovskaya I.G., Medvedev A.E.
Lecture: prospects of hormone analyses in saliva
|
 |
| EXPERIMENTAL STUDIES |
| 308-321 |
Naryzhny S.N., Ronzhina N.L., Mainskova M.A., Belyakova N.V., Pantina R.A., Filatov M.V.
Development of barcode and proteome profiling of glioblastoma
|
|
| 322-331 |
Avilova E.A., Andreeva O.E., Shatskaya V.A., Krasilnikov M.A.
The role of protein kinase PAK1 in the regulation of estrogen-independent growth of breast cancer
|
|
| 332-337 |
Fadeeva Yu.I., Antipova N.V., Baskova I.P., Zavalova L.L.
Highly active fractions of the medicinal leech recombinant destabilase-lysozyme
|
|
| 338-347 |
Bondarenko V.M., Alexeev Yu.V., Mislavsky O.V., Ponomarev G.V.
Perspectives of disodium salt 2.4-di(1-metoxyethyl)-deuteroporphyrin – IX (“dimegin”) application for photodynamic therapy in non-oncologic cases
|
|
| 348-353 |
Sanzhakov M.A., Ipatova O.M., Prozorovskiy V.N., Medvedeva N.V., Torkhovskaya T.I.
Interaction of rifampicin embedded in phospholipid nanoparticles with blood plasma lipoproteins
|
|
| 354-363 |
Shelkovnikova T.A., Ustyugov A.A., Kokhan V.S., Tarasova T.V., Medvedeva V.K., Khrytankova I.V., Bachurin S.O., Ninkina N.N.
Study into molecular targets of a neuroprotective compound dimebon using a transgenic mice line
|
|
| 364-371 |
Savilov P.N.
Effect of hyperbaric oxygenation on metabolism of glutamine in the liver
|
|
| CLINICAL STUDIES |
| 372-377 |
Globa A.G., Alekseev Y.I., Arzumanyan V.G., Zaborova V.A., Guridov A.A.
The use of real time PCR for quantitative determination of some propionic bacteria residing on human skin
|
|
| 378-388 |
Ivanenko N.B., Ivanenko A.A., Solovyev N.D., Navolotskii D.V., Pavlova O.V., Ganeev A.A.
Determination of Al, Be, Cd, Co, Cr, Mn, Ni, Pb, Se and Tl in whole blood by atomic absorption spectrometry without preliminary sample digestion
|
|
| 389-396 |
Petrushova O.P., Mikulyak N.I.
Proteolytic activity of fetoplacental complex in normal and pathology
|
|